Michel L. Tremblay, Ph.D. is a James McGill Professor and former director of the Goodman Cancer Research Centre at McGill University, Montreal, Quebec. His laboratory works on characterizing the function and regulation of several members of the Protein Tyrosine Phosphatase (PTP) gene family using both biochemical and genetic approaches. Dr. Tremblay has over 10 patents filed and over 140 publications in the field of Protein Tyrosine Phosphatases and he is a recognized figure internationally on this gene family and their function in cancer, diabetes and neuroscience. Based on his expertise, he served on several boards of biotech/pharma industry companies, two of which he initiated the foundation, and he continues to pursue various research projects in partnership with the private sector. He served as the first coordinator of the Quebec Node of the Terry Fox Research Institute and was member of the Scientific Committee of the Québec Consortium for Drug Discovery. He is recipient of an FRSQ chercheur national; honored as the Jeanne and J.–Louis Lévesque Chair in Cancer Research and as a Fellow to the Academy of Sciences of the Royal Society of Canada. He recently undertook several new assignments, such as; being the secretary general of the International Society of Pathophysiology, and a member of the Advisory Committee on Research for the Canadian Cancer Society.